Sysmex study tests FCCS method to assess VWF multimer size for von Willebrand disease subtyping

Sysmex highlighted a clinical study using FCCS to assess von Willebrand factor multimer size for von Willebrand disease subtyping. Findings are scheduled for presentation on Oct. 11, 2026 at the 88th Annual Meeting of the Japanese Society of Hematology. The work positions FCCS as a potential alternative approach for disease subtyping, targeting more actionable classification for clinical testing workflows. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sysmex Corporation published the original content used to generate this news brief on October 13, 2026, and is solely responsible for the information contained therein. (C)